Stocks
Neurotrope (NTRP) EBITDA US GAAP (year values) |
|||||||||
| FY2022 | FY2023 | FY2024 | FY2025 | FY2026 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | -7.28 | -4.24 | -7.70 | -13.7 | -12.8 | |||
| Changes by years, y/y, % | +43% | -42% | -100% | +78% | +22.0% | ||||
Neurotrope. EBITDA US GAAP, bln rub
Neurotrope. EBITDA US GAAP, changes, %
Neurotrope. EBITDA US GAAP, sum by quarters, bln rub
Neurotrope (NTRP) EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q4 | FY2026Q1 | FY2026Q2 | FY2026Q3 | FY2026Q4 | LTM ? | |||
| EBITDA, bln rub | ? | -3.04 | -3.96 | -2.39 | -2.65 | -4.69 | -12.8 | |
| Changes by years, y/y, % | -27% | +63% | +54% | |||||
| Changes by quarters, q/q, % | +87% | +30% | -40% | +11% | +77% | |||
